Shareholders' Equity (Tables)

3 Months Ended

Mar. 31, 2016

Equity [Abstract]

Share-Based Activity

Other information pertaining to share-based activity during the three months ended March 31, 2016 and 2015 was as follows (in thousands):

	Three Months Ended March 31,
	2016		2015
Share-based compensation expense	$	7,168	$	3,709
Fair value of shares vested	16,961		11,474
Cash received from option exercises	276		1,746
Tax benefit from exercises of share based awards	3,605		3,317

Schedule Of Changes In Non-Vested Restricted Shares

A summary of the status of non-vested restricted shares at March 31, 2016 and changes during the three months ended March 31, 2016 is as follows:

			Weighted
	Number		Average
	of Shares		Grant Price
Non-vested shares at December 31, 2015	734,101		$	44.73
Shares granted	566,763		73.98
Shares vested	(231,862	)	36.27
Shares forfeited	(5,407	)	55.40
Non-vested shares at March 31, 2016	1,063,595		$	62.11

Schedule Of Stock Option Activity

A summary of stock option activity for the three months ended March 31, 2016 is summarized as follows:

					Weighted
			Weighted		Average
			Average		Remaining
	Number		Exercise		Contractual
	of Shares		Price		Term (in years)
Outstanding at December 31, 2015	33,751		$	22.98	1.1
Options exercised with total intrinsic value of $0.6 million	(12,667	)	21.78
Options terminated	(4,200	)	21.07
Outstanding, Vested and Exercisable at March 31, 2016 with an aggregate intrinsic value of $0.9 million	16,884		$	24.36	0.8

Schedule Of Reconciliation Of Numerator And Denominators Of Basic And Diluted Earnings Per Share

The following is a reconciliation of the numerator and denominators of basic and diluted earnings per share (in thousands, except per share amounts):

	Three Months Ended March 31,
	Earnings		Shares	Per Share
	(Numerator)		(Denominator)	Amount
2016:
Net earnings attributable to AmSurg Corp. common shareholders (basic)	$	28,599	53,665	$	0.53
Effect of dilutive securities, options and non-vested shares	—		336
Net earnings attributable to AmSurg Corp. common shareholders (diluted)	$	28,599	54,001	$	0.53
2015:
Net earnings attributable to AmSurg Corp. common shareholders (basic)	$	18,774	47,572	$	0.39
Effect of dilutive securities, options and non-vested shares	—		333
Net earnings attributable to AmSurg Corp. common shareholders (diluted)	$	18,774	47,905	$	0.39